Grand Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Grand Pharmaceutical Group has a total shareholder equity of HK$15.9B and total debt of HK$4.5B, which brings its debt-to-equity ratio to 28.1%. Its total assets and total liabilities are HK$24.9B and HK$9.0B respectively. Grand Pharmaceutical Group's EBIT is HK$3.0B making its interest coverage ratio 17.8. It has cash and short-term investments of HK$3.2B.
Key information
28.1%
Debt to equity ratio
HK$4.47b
Debt
| Interest coverage ratio | 17.8x |
| Cash | HK$3.23b |
| Equity | HK$15.90b |
| Total liabilities | HK$9.00b |
| Total assets | HK$24.90b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MX6A's short term assets (HK$8.2B) exceed its short term liabilities (HK$6.4B).
Long Term Liabilities: MX6A's short term assets (HK$8.2B) exceed its long term liabilities (HK$2.6B).
Debt to Equity History and Analysis
Debt Level: MX6A's net debt to equity ratio (7.8%) is considered satisfactory.
Reducing Debt: MX6A's debt to equity ratio has reduced from 29.4% to 28.1% over the past 5 years.
Debt Coverage: MX6A's debt is well covered by operating cash flow (42.6%).
Interest Coverage: MX6A's interest payments on its debt are well covered by EBIT (17.8x coverage).